Sunday, 19 January 2020

BioTech News

  • Hatchtech publishes safety data for DeOvo

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

    Singapore: Australia-based specialty pharmaceutical company Hatchtech published data describing the mechanism of action of the active ingredient (Ha44) in its lead head lice product DeOvo, ...Read more

  • US FDA approves first drug for HIV prevention

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2012

    Singapore: The US Food and Drug Administration (FDA) has approved once-daily oral Truvada (emtricitabine and tenofovir disoproxil fumarate) by Gilead Sciences, in combination with safer sex...Read more

  • A*Star center promotes staff health, wins award

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 04 Dec, 2012

    Singapore: A*Star's Institute of Bioengineering and Nanotechnology (IBN), won the Singapore HEALTH (Helping Employees Achieve Life-Time Health) Platinum Award 2012 for its efforts in promo...Read more

  • BIOTEC researcher gets Thai young scientist award

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Aug, 2012

    Singapore: Dr Sithichoke Tangphatsornruang, head, genomic research laboratory, BIOTEC, has been chosen by the Foundation for the Promotion of Science and Technology under the Patronage of H...Read more

  • Is China bioscience really slowing down?

    BioTech |  Opinion | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Is China bioscience slowing down? From the numbers that have been put together by the BioSpectrum Asia Pacific Bioscience Industry Survey 2013, it does look so. However, a little deeper loo...Read more

  • Chugai pharma to invest in its research center in Singapore

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 02 Feb, 2015

    Singapore: Japan-based drug giant, Chugai pharmaceuticals recently announced that the company planned to invest nearly S$476 million into its research institute in Singapore-Chugai Pharmabo...Read more

  • Biocon gets positive results in insulin glargine study

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

    Bangalore: Biocon has announced positive results from a phase I comparative study conducted in Germany of its biosimilar insulin glargine in type 1 diabetes mellitus (T1DM) patients. This ...Read more

  • Novartis: Malaysia signed MoU only with us

    BioTech |  Influencers | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Malaysia has geared itself to become a high-income developed nation by 2020. Working towards that goal, the government had launched the economic transformation programme (ETP), which is exp...Read more

  • Phylogica to convert notes to raise $1.6 mn

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

    Singapore: Phylogica has agreed to raise $1.6 million of new capital through a placement of 16,000 unlisted converting notes each with an issue price of $100. The issue of the converting no...Read more

  • Merck launches chromatography media

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    Singapore: Merck Millipore, the life science division of Merck, has launched two comprehensive chromatography portfolio to further accelerate downstream purification and improve process eff...Read more

  • Mutation that causes anemia, also causes cancer

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Singapore: Research by Dr David S Terman of Jenomic Research Institute from Duke University, US, revealed that the genetic mutation that causes sickle cell anemia also turns red blood cell...Read more

  • New hope for personalized cancer therapy

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

    Singapore: A team of scientists led by Associate Professor Zeng Qi from A*Star's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians pr...Read more

  • Allon neuro protein gets US, NZ, Mexico patent

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Allon Therapeutics received composition of matter patents from the US, New Zealand and Mexico for a new family of peptides that the company believes has the potential to be deve...Read more

  • Abbott separates its R&D arm, calls it AbbVie

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2012

    Singapore: Abbott has decided to separate its research-based pharmaceuticals business, which will be known as AbbVie. Abbott also declared a special dividend distribution of all of the outs...Read more

  • Aus univ gets massive funding for TB, HPV R&D

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jan, 2013

    Singapore: University of Queensland (UQ) has secured support from the federal government for two research of its projects, aimed at treating papilloma virus and tuberculosis infections. The...Read more

  • Mayo Clinic, Cancer Genetics form OncoSpire JV

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 23 May, 2013

    Singapore: Mayo Clinic and Cancer Genetics have collaborated to form OncoSpire Genomics, a 50:50 joint venture (JV) with the singular goal of improving cancer care by discovering and commer...Read more

  • Japan Minister: Dont be afraid of new science strategy

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Japanese scientists are skeptical about the country's new strategy for economic growth, which includes an emphasis on applied biomedical research. Several life science organizati...Read more

  • 3SBio to merge with Decade Sunshine

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2013

    Singapore: China-based 3SBio entered into an agreement and plan-of-merger with Decade Sunshine, an exempted company with limited liability incorporated under the laws of the Cayman Islands...Read more



Podcast

 

Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls